Designed for clinicians at every level, this book addresses the origin, assessment, diagnosis, and treatment of these disorders in a comprehensive, up-to-date, and compelling manner. Following a comprehensive overview of core principles, the book provides detailed coverage of specific DSM-5 diagnoses: generalized anxiety disorder, obsessive-compulsive and related disorders, panic disorder and agoraphobia, social anxiety disorder, specific phobia, and trauma- and stressor-related disorders.

This one-stop resource for both clinicians and researchers details not only the rigorous diagnostic schemas, sophisticated psychobiological models, and effective pharmacotherapy and psychotherapy interventions developed during the past few decades but also the latest advances in research, theory, and clinical knowledge in this diverse field.

Designed for clinicians at every level, The American Psychiatric Association Publishing Textbook of Anxiety, Trauma, and OCD-Related Disorders addresses the origin, assessment, diagnosis, and treatment of these disorders in a comprehensive, up-to-date, and compelling manner. Fresh voices are everywhere in this authoritative revision of the classic text, as more than 60% of the contributors are new. They join stalwarts from the previous edition -- experts who bring stellar credentials and a discerning eye to the task of revising the text to reflect cutting-edge scholarship and evidence-based clinical knowledge. Following a comprehensive overview of core principles, the book provides detailed coverage of specific DSM-5 diagnoses: generalized anxiety disorder, obsessive-compulsive and related disorders, panic disorder and agoraphobia, social anxiety disorder, specific phobia, and trauma- and stressor-related disorders. Each section presents the latest thinking on phenomenology and pathogenesis, then provides evidence-based clinical recommendations for pharmacotherapy and psychotherapy. New and noteworthy material includes the following: Two new chapters focus on the features, phenomenology, and course of acute and integrated grief, as well as the epidemiology, clinical features, evaluation, and pathophysiology of complicated grief (CG), which affects a significant minority. Proper treatment of CG is critical, because once it persists beyond 6 months, impairment may last for years, if not a lifetime. Accordingly, a separate chapter is devoted to treatment options, including a hybrid of cognitive-behavioral, interpersonal, motivational interviewing, and psychodynamic methods. The Unified Protocol (UP) for Transdiagnostic Treatment of Emotional Disorders is examined in a fascinating new chapter. The UP is a promising treatment with empirical support for reduction of both symptoms and higher-order temperamental changes, such as changes in neuroticism, an underlying mechanism associated with onset and maintenance of emotional disorders. The chapter on anxiety disorders in late life is completely new and emphasizes the prevalence of anxiety in this population and its likelihood of remaining undetected and untreated. The epidemiology, diagnosis, and treatment of these disorders are examined in detail so that the reader will recognize the clinical features, be able to differentiate them from depression, and can identify appropriate treatment, whether pharmacological or psychotherapeutic. Each chapter features a concise list of key clinical points to help the reader focus on the most important material for study, as well as a list of recommended reading for those who wish to learn more. Grounded in the latest research, clinically rich, and pedagogically strong, The American Psychiatric Association Publishing Textbook of Anxiety, Trauma, and OCD-Related Disorders is the go-to text for mental health clinicians looking for evidence-based knowledge and support.

"Schizophrenia remains the most challenging of mental disorders confronted by psychiatrists and other mental health providers. Its primary manifestations-psychotic symptoms and cognitive impairment-profoundly affect the functioning of individuals with schizophrenia. This is an updated textbook covering the current state of knowledge about schizophrenia, including its causes, nature, presentation, and treatment. Chapters are written by a roster of experts in "--

The definitive treatment textbook in psychiatry, this fifth edition of Gabbard's Treatments of Psychiatric Disorders has been thoroughly restructured to reflect the new DSM-5® categories, preserving its value as a state-of-the-art resource and increasing its utility in the field. The editors have produced a volume that is both comprehensive and concise, meeting the needs of clinicians who prefer a single, user-friendly volume. In the service of brevity, the book focuses on treatment over diagnostic considerations, and addresses both empirically-validated treatments and accumulated clinical wisdom where research is lacking. Noteworthy features include the following: Content is organized according to DSM-5® categories to make for rapid retrieval of relevant treatment information for the busy clinician. Outcome studies and expert opinion are presented in an accessible way to help the clinician know what treatment to use for which disorder, and how to tailor the treatment to the patient. Content is restricted to the major psychiatric conditions seen in clinical practice while leaving out less common conditions and those that have limited outcome research related to the disorder, resulting in a more streamlined and affordable text. Chapters are meticulously referenced and include dozens of tables, figures, and other illustrative features that enhance comprehension and recall. An authoritative resource for psychiatrists, psychologists, and psychiatric nurses, and an outstanding reference for students in the mental health professions, Gabbard's Treatments of Psychiatric Disorders, Fifth Edition, will prove indispensable to clinicians seeking to provide excellent care while transitioning to a DSM-5® world.

Anxiety disorders are among the most prevalent, persistent, disabling, and costly psychiatric disorders, yet they are often underdiagnosed and undertreated. Fortunately, there have been major advances in understanding and treating these conditions in recent years; this is one of the most exciting areas in modern medicine. This clinical manual has earned its place in the literature as one of just a few volumes that covers all of the major anxiety disorders and presents integrated contributions from both psychopharmacologists and psychotherapists -- all in one compact work written for busy clinicians. Though concepts of anxiety have long enjoyed a central position in philosophical and psychoanalytic theories, empirical research on anxiety disorders has a relatively short history. Here, 16 experts discuss advances in diagnosis, assessment (including relevant rating scales), pharmacotherapy, and psychotherapy. This volume begins by reviewing recent important diagnostic, epidemiological, neurobiological, and treatment findings -- all of which have significant implications for clinicians. Subsequent chapters cover Panic disorder and agoraphobia -- Laboratory studies of fear have significantly advanced our understanding of the neurocircuitry and neurochemistry of panic. Furthermore, panic disorder is now readily treated with both medications and psychotherapy. Specific phobia -- Viewed for many years as mild and even trivial, this common disorder is now recognized for its very real associated distress and impairment. Exposure therapy is the treatment mainstay, though pharmacotherapy should be considered particularly when there is comorbidity. Social phobia (or social anxiety disorder) -- In the past few years, the first FDA-approved medications for this disorder have been made available. Cognitive-behavioral therapy is also effective for the treatment of this underdiagnosed and undertreated condition. Obsessive-compulsive disorder (OCD) -- OCD was the first disorder where it was shown that both specific medications and cognitive-behavioral techniques resulted in normalization of activity in particular brain structures. It is now possible to provide patients with integrated treatment approaches. Posttraumatic stress disorder (PTSD) -- Once viewed as a normal reaction to trauma, PTSD is increasingly understood as a pathological response, characterized by specific psychobiological dysfunctions. Again, there have been exciting advances in the treatment of this disorder, with the release of the first FDA-approved agents for PTSD. Generalized anxiety disorder (GAD) -- For a number of years GAD was thought of as a residual disorder occasionally seen in combination with more primary conditions. Nowadays, we know that GAD is an independent condition that is prevalent, persistent, and disabling. Busy residents and psychiatrists in active clinical practice, psychologists, primary care practitioners, and other mental health professionals will find this clinical manual -- with its integrated approach of both pharmacotherapy and psychotherapy -- a valuable tool in their everyday practices.

As disorders in which stress or fear play major roles present an increasing need for psychiatric care around the world, this volume summarizes current research to determine whether a specific group of stress-induced and fear-based disorders form a distinct syndrome independent from other anxiety disorders such as obsessive-compulsive disorder or generalized anxiety. Intended to suggest DSM-V revisions regarding the classification of these disorders, Stress-Induced and Fear Circuitry Disorders reflects findings that may lead to more refined treatments for these specific anxiety disorders based on a better understanding of the biological and environmental factors that contribute to their development and symptoms. Thirty contributors, all international authorities on this group of mental illnesses, clarify how these disorders develop and what factors contribute to symptomatology. Focusing on posttraumatic stress disorder, panic disorder and agoraphobia, social phobias, and specific phobia, the authors explore the possibility of linking the classification and etiology of these conditions by showing that they may be closely related in terms of brain pathophysiology. In addition to assessing the stability of disorders across patient lifespans and determining whether they form a cohesive and distinct group, the authors examine shared etiologies and biopsychosocial correlates, as well as aspects unique to each disorder. Among the book's specific insights: How minority populations, particularly African Americans, are differentially affected by these disorders. The neuronal mechanisms of normal fear and anxiety, including how changes in the genetics of the serotonin system can increase the risk of anxiety. The role of cognition in symptom presentation and treatment, revealing cognitive biases that favor the processing of threat-related information. The contribution of stress and psychosocial factors, such as peer victimization and childhood sexual abuse. The use of neuroimaging to analyze neural structure and function for each of the four disorder groups. How neurochemistry and neuroendocrine markers may aid in classification of anxiety disorders. The contribution of substance abuse to the pathophysiology of these disorders. Given the importance of changes to DSM for professional education and public health, this book offers important new ways of thinking about stress-induced and fear-based disorders. It not only allows researchers to more accurately assess their diagnostic classifications, but also can help clinicians more effectively communicate with patients regarding the nature of their illness and the importance of adhering to treatment regimens.

This is a major international textbook for psychiatrists and other professionals working in the field of mental healthcare. With contributions from opinion-leaders from around the globe, this book will appeal to those in training as well as to those further along the career path seeking a comprehensive and up-to-date overview of effective clinical practice backed by research evidence. The book is divided into cohesive sections moving from coverage of the tools and skills of the trade, through descriptions of the major psychiatric disorders and on to consider special topics and issues surrounding service organization. The final important section provides a comprehensive review of treatments covering all of the major modalities. Previously established as the Essentials of Postgraduate Psychiatry, this new and completely revised edition is the only book to provide this depth and breadth of coverage in an accessible, yet authoritative manner.

This book is a guide for psychologists working with substance users in different healthcare settings, from private clinical practice to larger health institutions and community services. It presents a comprehensive overview of the different aspects involved with substance use disorders from a psychological perspective, from prevention to recovery. The volume offers an integrative view about neurobiological, behavioral and psychosocial aspects related to becoming a substance user; shows how psychological assessment tools can be used to diagnose substance use disorders; describes how different kinds of psychotherapy can be applied in the treatment of substance use disorders; and presents a range of evidence-based clinical and social interventions designed for both prevention and treatment of substance use disorders. Apart from covering the whole range of services related to the prevention, diagnosis and treatment of substance use disorders, the volume also shows how these issues can be approached from different theoretical perspectives within psychology, such as: Behavioral and Cognitive Psychology Neuropsychology Existential Psychology Phenomenology Psychoanalysis Analytical Psychology Community and Social Psychology Psychology of Substance Abuse: Psychotherapy, Clinical Management and Social Intervention will be a useful resource for psychologists and other health professionals working with substance users, as well as to undergraduate and graduate students looking for a comprehensive introduction to the psychology of substance abuse.